Cargando…
Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
OBJECTIVES: The effects of masupirdine on the neuropsychiatric symptoms were explored. METHODS: Masupirdine (SUVN‐502) was evaluated for its effects on cognition in patients with moderate AD. The prespecified primary outcome showed no drug‐placebo difference. Post hoc analyses of domains of the 12‐i...
Autores principales: | Nirogi, Ramakrishna, Jayarajan, Pradeep, Benade, Vijay, Shinde, Anil, Goyal, Vinod Kumar, Jetta, Satish, Ravula, Jyothsna, Abraham, Renny, Grandhi, Venkata Ramalingayya, Subramanian, Ramkumar, Pandey, Santosh Kumar, Badange, Rajesh Kumar, Mohammed, Abdul Rasheed, Jasti, Venkat, Ballard, Clive, Cummings, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828442/ https://www.ncbi.nlm.nih.gov/pubmed/36168659 http://dx.doi.org/10.1002/gps.5813 |
Ejemplares similares
-
Effect of Concurrent Use of Memantine on the Efficacy of Masupirdine (SUVN-502): A Post Hoc Analysis of a Phase 2 Randomized Placebo-Controlled Study
por: Nirogi, Ramakrishna, et al.
Publicado: (2022) -
Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
por: Nirogi, Ramakrishna, et al.
Publicado: (2022) -
Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
por: Nirogi, Ramakrishna, et al.
Publicado: (2023) -
Evaluation of in vitro and in vivo anticancer potential of two 5-acetamido chalcones against breast cancer
por: Wankhede, Sonal, et al.
Publicado: (2017) -
Protective Effects of Aqueous Extract of Solanum nigrum Linn. Leaves in Rat Models of Oral Mucositis
por: Patel, Alkesh, et al.
Publicado: (2014)